Yep Sarto....that's it
but just remember it does not include Europe, China, Japan, Korea, India, Indonesia or Iceland ???
and it does not include Quest Celera's test for Lung Cancer
and it does not include the range of other diagnostic tests under collaboration.
and it does not include the potential therapeutic market
and it does not include the "hair" stuff with world wide distribution.
start crunching the Nos on this and a 10+ bagger seems pretty reasonable in the medium - 5 years term.
GLTA
peb 3rd us provider signed for cxbladder, page-8
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
